Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Aimovig 140mg/1ml solution for injection pre-filled pens (Novartis Pharmaceuticals UK Ltd) |
| BNF code | 0407042T0BBABAB |
| Virtual Medicinal Product | Erenumab 140mg/1ml solution for injection pre-filled disposable devices |
| Name | Aimovig 140mg/1ml solution for injection pre-filled pens |
| Date of name applicability | 28 Feb 2020 |
| Previous name | Aimovig 140mg/1ml solution for injection pre-filled pen |
| Supplier | Novartis Pharmaceuticals UK Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Subcutaneous |
| Actual Medicinal Product Packs | |
| Aimovig 140mg/1ml solution for injection pre-filled pens (Novartis Pharmaceuticals UK Ltd) 1 pre-filled disposable injection | |
dm+d data retrieved from TRUD: release NHSBSA_4.2.0_20240415000001, imported on 15th April 2024 at 05:09:22.